Available option
10mg / 1.2mL
Staff-prepared solution
- Strength
- 10mg / 1.2mL
- Format
- Staff-prepared solution
Bear Biotech catalogue
TB-500
Thymosin beta-4-related research material
- Actin dynamics
- Cell migration
- Wound-repair models
Available presentations
Choose a strength and format
Each available presentation is listed separately. Current prices are confirmed from the Bear Biotech catalogue.
Available option
10mg
Lyophilised powder
- Strength
- 10mg
- Format
- Lyophilised powder
Research overview
What is TB-500?
TB-500 is widely associated with thymosin-beta-4 research into cell migration, actin dynamics, angiogenesis and tissue-repair biology. Most of the mechanistic interest comes from preclinical thymosin-beta-4 literature, so exact material identity matters when interpreting published findings. Bear Biotech positions TB-500 as a research material, not as a proven injury treatment.
Identity-dependent; mainly preclinical
Research focus
Key research areas
TB-500 research: cell migration and repair biology
TB-500 is a commercial designation associated with thymosin beta-4-related material. Sequence identity is essential before literature on actin dynamics or cell-migration models can be applied. Published findings concern defined experimental materials and do not establish the identity, quality, safety, efficacy or equivalence of Bear Biotech catalogue material.
- Actin dynamics
- Cell migration
- Wound-repair models
Representative primary research
Representative research
An analytical study identified TB-500 as a synthetic N-acetylated LKKTETQ fragment related to thymosin beta-4.
- Doping control analysis of TB-500, a synthetic version of an active region of thymosin beta-4 ↗ Original analytical and equine study; it does not establish human effects or full-length thymosin beta-4 identity.
These sources provide research context only. They do not verify the identity, quality or equivalence of a Bear Biotech catalogue batch; the matched lot-specific batch record remains controlling.
Specifications
Product information
- Material identity
- TB-500
- Research category
- Thymosin beta-4-related research material
- Evidence position
- Identity-dependent; mainly preclinical
- Recorded formats
- Staff-prepared solution · Lyophilised powder
- Batch-record basis
- The matched lot-specific record controls identity and analytical claims.
- Intended use
- Controlled laboratory research only.
Research questions
Evidence and identity questions
Why is actin organisation central to TB-500 research?
TB-500 research commonly examines thymosin-beta-4-related control of actin organisation, a process relevant to cell shape and movement. Exact sequence identity is necessary before applying that literature.
What can cell-migration models measure when studying TB-500?
Cell-migration studies use defined cellular or animal systems to measure movement, cytoskeletal organisation and related repair-model endpoints. They do not establish an injury treatment.
Why must TB-500 identity be distinguished from thymosin beta-4 literature?
TB-500 evidence is identity-dependent and mainly preclinical. Results for thymosin beta-4 or a defined fragment should not be transferred to an unverified commercial material.
Batch documentation
Lot-specific records stay connected to the order
Eligible lot-specific documentation may be viewed or requested from the registered Bear Biotech account when available for the applicable order.
Open Bear Biotech accountResearch use only
Controlled laboratory research material
Not for human or veterinary consumption. Administration, dosing and therapeutic guidance are not provided.